Pediatrics 2011; 127: 1034–1042.
29. Hodapp M, Klisch C, Mall V, Vry J, Berger W, Faist M. Mo-
dulation of soleus H-reflexes during gait in children with
cerebral palsy. J Neurophysiol 2007; 98: 3263–3268.
30. Robin J, Graham HK, Selber P, Dobson F, Smith K, Baker R.
Proximal femoral geometry in cerebral palsy: a population-
based cross-sectional study. J Bone Joint Surg Br 2008;
90: 1372–1379.
31. Noonan KJ, Jones J, Pierson J, Honkamp NJ, Leverson G.
Hip function in adults with severe cerebral palsy. J Bone
Joint Surg Am 2004; 86–A: 2607–2613.
32. Miller F, Liang Y, Merlo M, Harcke HT. Measuring anteversion
and femoral neck-shaft angle in cerebral palsy. Dev Med
Child Neurol 1997; 39: 113–118.
33. Chan G, Miller F. Assessment and treatment of children with
cerebral palsy. Orthop Clin North Am 2014; 45: 313–325.
34. Day SM, Wu YW, Strauss DJ, Shavelle RM, Reynolds RJ.
Change in ambulatory ability of adolescents and young
adults with cerebral palsy. Dev Med Child Neurol 2007;
49: 647–653.
35. Trinh A, Wong P, Fahey MC, Brown J, Churchyard A, Strauss
BJ, et al. Musculoskeletal and endocrine health in adults
with cerebral palsy: new opportunities for intervention. J
Clin Endocrinol Metab 2016; 101: 1190–1197.
36. Wright NC, Looker AC, Saag KG, Curtis JR, Delzell ES,
Randall S, et al. The recent prevalence of osteoporosis
and low bone mass in the United States based on bone
mineral density at the femoral neck or lumbar spine. J
Bone Miner Res 2014; 29: 2520–2526.
37. Hall AJ, Stubbs B, Mamas MA, Myint PK, Smith TO. Asso-
ciation between osteoarthritis and cardiovascular disease:
581
systematic review and meta-analysis. Eur J Prev Cardiol
2016; 23: 938–946.
38. Veronese N, Stubbs B, Solmi M, Smith TO, Noale M, Coo-
per C, et al. Association between lower limb osteoarthritis
and incidence of depressive symptoms: data from the
osteoarthritis initiative. Age Ageing 2017; 46: 470–476.
39. Smith KJ, Peterson MD, O’Connell NE, Victor C, Liverani S,
Anokye N, et al. Risk of depression and anxiety in adults
with cerebral palsy. JAMA Neurol 2018 [Epub ahead of
print].
40. Strauss D, Cable W, Shavelle R. Causes of excess mor-
tality in cerebral palsy. Dev Med Child Neurol 1999; 41:
580–585.
41. Christensen D, Van Naarden Braun K, Doernberg NS,
Maenner MJ, Arneson CL, Durkin MS, et al. Prevalence of
cerebral palsy, co-occurring autism spectrum disorders,
and motor functioning – Autism and Developmental Disa-
bilities Monitoring Network, USA, 2008. Dev Med Child
Neurol 2014; 56: 59–65.
42. Kerr EA, McGlynn EA, Van Vorst KA, Wickstrom SL. Mea-
suring antidepressant prescribing practice in a health care
system using administrative data: implications for quality
measurement and improvement. Jt Comm J Qual Improv
2000; 26: 203–216.
43. Leslie WD, Lix LM, Yogendran MS. Validation of a case de-
finition for osteoporosis disease surveillance. Osteoporos
Int 2011; 22: 37–46.
44. Doktorchik C, Patten S, Eastwood C, Peng M, Chen G, Beck
CA, et al. Validation of a case definition for depression in
administrative data against primary chart data as a refe-
rence standard. BMC Psychiatry 2019; 19: 9.
Prevalence of osteoarthritis among adults with cerebral palsy
J Rehabil Med 51, 2019